The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.
Coronary Artery Disease and Diabetes Mellitus
Open accessAbstract
Diabetes mellitus (DM) is a major risk factor for cardiovascular disease. Near-normal glycemic control does not reduce cardiovascular events. For many patients with 1- or 2-vessel coronary artery disease, there is little benefit from any revascularization procedure over optimal medical therapy. For multivessel coronary disease, randomized trials demonstrated the superiority of coronary artery bypass grafting over multivessel percutaneous coronary intervention in patients with treated DM. However, selection of the optimal myocardial revascularization strategy requires a multidisciplinary team approach ('heart team'). This review summarizes the current evidence regarding the effectiveness of various medical therapies and revascularization strategies in patients with DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dysfunction of multiple organ systems manifests similarly in diabetes as it does during normal chronological ageing, but in diabetes this frequently occurs at a younger age [2–4].”
From Cellular senescence: at the nexus between ageing and diabetes (2019) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Heart Disease and Stroke Statistics—2014 Update
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,264
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Cited by
Sorted by citations
Items 201–222 of 222
Ullah, D. S., Iqbal, D. S. J., Javed, D. H., Kazim, A. H., Khan, S., & Kakar, A. W. (2024) · doi:10.53555/jptcp.v31i4.5373
Elkenany, N. M., Almasswary, A., Sabah, Z. U., Agiba, N. A., Elmahdy, H. K., Elsherbiny, E. A. Y., Said, S. R. A., Ewis, A. M. A., Ahmed, M., Saleh, R. A. M., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5642306/v1
Jahanzaib, M., Ayoub, T., Noman, A., Yaqoob, A., & Aslam, B. (2025) · Insights-Journal of Health and Rehabilitation · doi:10.71000/a232p273
Teja, R., Priya Darshini, N., & Usha Rani, N. (2025) · A and V Pub International Journal of Nursing and Medical Research · doi:10.52711/ijnmr.2025.06
Ali, S. M. N., Ali, J., Rahman, J., Shah, A., Amin, M., & Ullah, Z. (2025) · Journal of medical & health sciences review. · doi:10.62019/kjpwfw60
Sumarno, A., Silvia, H., & Rafingah, S. (2025) · Afiat · doi:10.34005/afiat.v11i1.4660
Diastolic Dysfunction in Normotensive Adult with Type 2 Diabetes Mellitus in Bangladesh
Alam, M. S., Kalam, S. T., Hasan, M. M., Uddin, M. G., & Khan, F. N. (2025) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_9_25
Klotho: A possible diagnostic biomarker and therapeutic target in diabetes complications
Hejrati, A., Zabihi, T., Riazi, S., & Sarv, F. (2025) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-025-01526-6
Parvez, M., Habib, M., Ali, A., Naila, B., Khattak, N. U. S., Wahab, M., Hira, K., & Afnan, M. (2025) · Cureus · doi:10.7759/cureus.91675
Assessment of the Risk of Atherogenicity and Cardiometabolic Health in Type II Diabetes Mellitus
Al-Fadhel, S. Z., Al-Ghuraibawi, N. H. A., & Mubarak, S. M. H. (2025) · Ars Pharmaceutica (Internet) · doi:10.30827/ars.v66i4.32268
Ali, Z. Q. M., Shiaa, N. R., Ali, M., & Al-Rubaye, A. A. (2025) · Annales Academiae Medicae Silesiensis · doi:10.18794/aams/208068
The Investigation into Correlation between Type 2 Diabetes Mellitus and the Gut Microbiota
Liu, S., & Zhu, A. M. (2025) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2025.1511022
Tibaut, M., Mankoč, S., & Petrovič, D. (2020) · Figshare · doi:10.6084/m9.figshare.13363998
Long-Term disease progression and incidence of complications in Type 2 Diabetes Mellitus
Pósfai, G., Gaetano, A. D., Kovács, L., & Eigner, G. (2025) · Conference proceedings/Conference proceedings - IEEE International Conference on Systems, Man, and Cybernetics · doi:10.1109/smc58881.2025.11342991
Mufti, H. N., Alshair, F. M., Alqahtani, A. K., Alqahtani, O., Alfaqih, M. A., Alsaeedi, A., Sanai, E. A., & Acosta, L. Z. (2026) · Journal of Cardiac Surgery · doi:10.1155/jocs/1825061
The Relationship between Diabetes Complications and the Intestinal Microbiota
Poczta, Z., Leśniak, C., Podeszwa, A., Różycka, M. A., Włoch, O., Siejek, A., Dobrowolska, A., & Zawada, A. E. (2026) · Current Diabetes Reviews · doi:10.2174/0115733998408978251206123827
Ji, Y., Zhou, J., Lian, Z., Shi, B., Pan, Y., Yin, Y., Liu, J., Zhao, G., Zhang, C., Zhu, H., et al. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02217-x
Cao, S., Ling, M., Zhang, X., Wu, W., Luo, M., Jiang, B. G., & Yuan, J. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06060-9
Management of coronary artery disease via simvastatin-loaded novasomes
Fouad, A. G., Belal, A., Gushgari, O. Y., Bawaked, R. A., Alshwail, F. A., & El‐Ela, F. I. A. (2026) · Journal of Microencapsulation · doi:10.1080/02652048.2026.2688996
Amani‐Beni, R., Dabaghi, G. G., Mohammadifard, N., Zarepur, E., Darouei, B., Rad, M. R., Haghighatdoost, F., Nouri, F., & Sarrafzadegan, N. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70280
Progressive coronary atherosclerosis in a porcine model of diabetes: a pilot study
Kushwaha, A. K., Marathe, J., Finnie, J. W., Tan, J. T. M., Manavis, J., Xiang, L., Ruchka, P., Bursill, C. A., Verjans, J. W. H., McLaughlin, R. A., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-68413-w
Anh, L. T., Hiệp, D. Q., Công, N. L. T., & Công, N. L. T. (2026) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.122.2026.1335
Metadata
- Authors
- Aronson, D., & Edelman, E. R.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Brigham and Women's Hospital (US)
- Venue
- Cardiology Clinics
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 32
- Issue
- 3
- Pages
- 439-455
- ISSN
- 0733-8651 (ISSN-L)
- PMC
- PMC4672945
- OpenAlex
- W2103962300
- Cited by
- 222
- References
- 125
- Citations by year
- 2026: 9 · 2025: 30 · 2024: 24 · 2023: 27 · 2022: 29 · 2021: 27 · 2020: 23 · 2019: 19 · 2018: 12 · 2017: 7 · 2016: 6 · 2015: 4 · 2014: 1
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cardiology Clinics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM049039)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- coronary artery disease, diabetes mellitus, glycemic control, cardiovascular risk, coronary revascularization, coronary artery bypass grafting, percutaneous coronary intervention, multivessel coronary artery disease, heart team, optimal medical therapy
- MeSH terms
- Coronary Artery Disease, Diabetes Mellitus, Humans, Hypoglycemic Agents, Myocardial Revascularization, Risk Factors, Global Health, Incidence, Prevalence, Glycemic Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
